Morgan Stanley analyst Matthew Harrison briefly weighed in on the preliminary flu vaccine data released by Moderna (NASDAQ: MRNA) this ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE